血糖値検査ストリップの世界市場2021年-2025年

◆英語タイトル:Global Blood Glucose Test Strips Market 2021-2025
◆商品コード:IRTNTR70614
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年5月26日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は、血糖値検査ストリップの世界市場規模が2021年から2025年まで年平均約10%成長し、67.7億ドルに達すると予測しています。本調査資料では世界の血糖値検査ストリップ市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(病院&診断研究所、在宅医療設備、POL)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・血糖値検査ストリップの世界市場規模:エンドユーザー別(病院&診断研究所、在宅医療設備、POL)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Blood Glucose Test Strips Market 2021-2025

Technavio has been monitoring the blood glucose test strips market and it is poised to grow by $ 6.77 bn during 2021-2025, progressing at a CAGR of almost 10% during the forecast period. Our report on blood glucose test strips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the number of diabetes cases and rising awareness about diabetes and growth of new marketing strategies In addition, increase in the number of diabetes cases and rising awareness about diabetes is anticipated to boost the growth of the market as well.

The blood glucose test strips market analysis includes end-user segment and geographic landscape.
Technavio’s blood glucose test strips market is segmented as below:

By End-user
• Hospitals and diagnostic laboratories
• Home care settings
• POL

By Geography
• North America
• Europe
• Asia
• ROW

This study identifies the availability of products on online channels as one of the prime reasons driving the blood glucose test strips market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on blood glucose test strips market covers the following areas:
• Blood glucose test strips market sizing
• Blood glucose test strips market forecast
• Blood glucose test strips market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose test strips market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Omnis Health LLC, Sanofi SA, Sinocare Inc., Teladoc Health Inc., and UniStrip Technologies LLC. Also, the blood glucose test strips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/blood-glucose-test-strips-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Hospitals and diagnostic laboratories – Market size and forecast 2020-2025
o Home care settings – Market size and forecast 2020-2025
o POL – Market size and forecast 2020-2025
o Market opportunity by End-user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Ascensia Diabetes Care Holdings AG
o B. Braun Melsungen AG
o F. Hoffmann-La Roche Ltd.
o LifeScan IP Holdings LLC
o Omnis Health LLC
o Sanofi SA
o Sinocare Inc.
o Teladoc Health Inc.
o UniStrip Technologies LLC
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: End user – Market share 2020-2025 (%)
• 22: Comparison by End user
• 23: Hospitals and diagnostic laboratories – Market size and forecast 2020-2025 ($ million)
• 24: Hospitals and diagnostic laboratories – Year-over-year growth 2020-2025 (%)
• 25: Home care settings – Market size and forecast 2020-2025 ($ million)
• 26: Home care settings – Year-over-year growth 2020-2025 (%)
• 27: POL – Market size and forecast 2020-2025 ($ million)
• 28: POL – Year-over-year growth 2020-2025 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2020-2025 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2020-2025 ($ million)
• 34: North America – Year-over-year growth 2020-2025 (%)
• 35: Europe – Market size and forecast 2020-2025 ($ million)
• 36: Europe – Year-over-year growth 2020-2025 (%)
• 37: Asia – Market size and forecast 2020-2025 ($ million)
• 38: Asia – Year-over-year growth 2020-2025 (%)
• 39: ROW – Market size and forecast 2020-2025 ($ million)
• 40: ROW – Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Abbott Laboratories – Overview
• 50: Abbott Laboratories – Business segments
• 51: Abbott Laboratories – Key offerings
• 52: Abbott Laboratories – Key customers
• 53: Abbott Laboratories – Segment focus
• 54: Ascensia Diabetes Care Holdings AG – Overview
• 55: Ascensia Diabetes Care Holdings AG – Product and service
• 56: Ascensia Diabetes Care Holdings AG – Key offerings
• 57: Ascensia Diabetes Care Holdings AG – Key customers
• 58: Ascensia Diabetes Care Holdings AG – Segment focus
• 59: B. Braun Melsungen AG – Overview
• 60: B. Braun Melsungen AG – Business segments
• 61: B. Braun Melsungen AG – Key offerings
• 62: B. Braun Melsungen AG – Key customers
• 63: B. Braun Melsungen AG – Segment focus
• 64: F. Hoffmann-La Roche Ltd. – Overview
• 65: F. Hoffmann-La Roche Ltd. – Business segments
• 66: F. Hoffmann-La Roche Ltd. – Key offerings
• 67: F. Hoffmann-La Roche Ltd. – Key customers
• 68: F. Hoffmann-La Roche Ltd. – Segment focus
• 69: LifeScan IP Holdings LLC – Overview
• 70: LifeScan IP Holdings LLC – Product and service
• 71: LifeScan IP Holdings LLC – Key offerings
• 72: LifeScan IP Holdings LLC – Key customers
• 73: LifeScan IP Holdings LLC – Segment focus
• 74: Omnis Health LLC – Overview
• 75: Omnis Health LLC – Product and service
• 76: Omnis Health LLC – Key offerings
• 77: Omnis Health LLC – Key customers
• 78: Omnis Health LLC – Segment focus
• 79: Sanofi SA – Overview
• 80: Sanofi SA – Business segments
• 81: Sanofi SA – Key offerings
• 82: Sanofi SA – Key customers
• 83: Sanofi SA – Segment focus
• 84: Sinocare Inc. – Overview
• 85: Sinocare Inc. – Product and service
• 86: Sinocare Inc. – Key offerings
• 87: Sinocare Inc. – Key customers
• 88: Sinocare Inc. – Segment focus
• 89: Teladoc Health Inc. – Overview
• 90: Teladoc Health Inc. – Business segments
• 91: Teladoc Health Inc. – Key offerings
• 92: Teladoc Health Inc. – Key customers
• 93: Teladoc Health Inc. – Segment focus
• 94: UniStrip Technologies LLC – Overview
• 95: UniStrip Technologies LLC – Product and service
• 96: UniStrip Technologies LLC – Key offerings
• 97: UniStrip Technologies LLC – Key customers
• 98: UniStrip Technologies LLC – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings LLC, Omnis Health LLC, Sanofi SA, Sinocare Inc., Teladoc Health Inc., UniStrip Technologies LLC

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血糖値検査ストリップの世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆